June 2019 42
y 4 6 Equit 2019 June High Conviction High Quarterly NewsletterQuarterly No. Selector Fund In this quarterly edition, we review performance and attribution for the quarter. We highlight the importance of innovation and culture within organisations and profile ResMed and Cochlear, two leading healthcare businesses. We visit Fisher & Paykel Healthcare in New Zealand and look at one of the biggest growth industries in the world today, cyber security. Photo. Selector analyst trekking through the Atlas Mountains and local Berber kids. Selector Funds Management Limited ACN 102756347 AFSL 225316 Level 8, 10 Bridge Street Sydney NSW 2000 Australia Tel 612 8090 3612 www.selectorfund.com.au P Selector is a boutique fund manager. Our team, combined, have over 150 years of experience in financial markets. We believe in long-term wealth creation and building lasting relationships with our investors. We focus on stock selection, the funds are high conviction, concentrated and index unaware. As a result, the portfolios have low turnover and produce tax effective returns. Selector has a 15-year track record of outperformance and we continue to seek businesses with leadership qualities, run by competent management teams, underpinned by strong balance sheets and with a focus on capital management. Selector High Conviction Equity Fund Quarterly Newsletter #64 CONTENTS IN BRIEF – JUNE QUARTER 3 PORTFOLIO OVERVIEW 5 PORTFOLIO CONTRIBUTORS 7 MARKET INSIGHTS AND OBSERVATIONS 13 INNOVATION + CULTURE = SUCCESS 17 RESMED INC. 20 WAKE-UP CALL 31 FISHER & PAYKEL HEALTHCARE – JUNE 2019 42 RISK OUT…UPFRONT 45 COMPANY VISIT DIARY – JUNE 2019 QUARTER 57 2 Selector Funds Management IN BRIEF – JUNE QUARTER Dear Investor, Looking back on 2019, it would be fair to say that few identify the businesses we want to own on a case by case foresaw how the events of the financial year would basis, understand them to the best of our abilities and unfold.
[Show full text]